These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3291557)

  • 41. [Comparative study of the efficacy of propafenone and amiodarone in the treatment of chronic ventricular extrasystole].
    Fauchier JP; Cosnay P; Rouesnel P; Moquet B; Huguet R; Wajman A
    Arch Mal Coeur Vaiss; 1986 Sep; 79(10):1495-505. PubMed ID: 2432845
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Efficacy of propafenone in the treatment of ventricular hyperkinetic arrhythmias in subjects with a history of myocardial infarction].
    Zoni Berisso M; Carratino L; De Caro E; Ferroni A; Vecchio C
    G Ital Cardiol; 1987 Mar; 17(3):233-8. PubMed ID: 3301504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A placebo-controlled study to determine the efficacy of oral disopyramide phosphate for the prophylaxis of ventricular dysrhythmias after acute myocardial infarction.
    Kumana CR; Rambihar VS; Tanser PH; Cairns JA; Gupta RN; Wildeman RA; Johnston M; Johnson AL; Gent M
    Br J Clin Pharmacol; 1982 Oct; 14(4):519-27. PubMed ID: 6753887
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
    Van Durme JP
    Acta Cardiol Suppl; 1980; (25):121-5. PubMed ID: 6990664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Propafenone: evaluation of antiarrhythmic efficacy in hyperkinetic ventricular arrhythmia using acute oral test].
    Boriani G; Capucci A; Balducelli M; Frabetti L; Marchesini B; Tomasi L; Ambrosioni E; Magnani B
    Cardiologia; 1988 Nov; 33(11):1061-7. PubMed ID: 2475253
    [No Abstract]   [Full Text] [Related]  

  • 47. Oral propafenone in the suppression of chronic stable ventricular arrhythmias.
    Schamroth L; Myburgh DP; Schamroth CL; Scholtz ME; Pincus DR; Kawalsky DL
    Chest; 1985 Apr; 87(4):448-51. PubMed ID: 3884286
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A controlled trial of propafenone for treatment of frequent and repetitive ventricular premature complexes.
    Salerno DM; Granrud G; Sharkey P; Asinger R; Hodges M
    Am J Cardiol; 1984 Jan; 53(1):77-83. PubMed ID: 6362387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dihydroquinidine versus disopyramide: efficacy in patients with chronic stable ventricular ectopy.
    Chimienti M; Panciroli C; Salerno JA; Regazzi-Bonora M; Previtali M; Cristiani D; Rondanelli R; Bobba P
    Clin Cardiol; 1984 Oct; 7(10):538-46. PubMed ID: 6386253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.
    Brogden RN; Todd PA
    Drugs; 1987 Aug; 34(2):151-87. PubMed ID: 3304965
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Heart rate variability in patients with ventricular arrhythmias: effect of antiarrhythmic drugs. Antiarrhythmic Drug Evaluation Group (ADEG).
    Zuanetti G; Latini R; Neilson JM; Schwartz PJ; Ewing DJ
    J Am Coll Cardiol; 1991 Mar; 17(3):604-12. PubMed ID: 1899680
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination antiarrhythmic treatment among class Ia, Ib, and II agents for ventricular arrhythmias.
    Tanabe T
    Cardiovasc Drugs Ther; 1991 Aug; 5 Suppl 4():827-34. PubMed ID: 1931759
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N; Terry L; Murphy ML; Thompson CH; Doherty JE; Sakhaii M; Dinh H
    Am Heart J; 1984 Aug; 108(2):285-9. PubMed ID: 6380253
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Propafenone in the treatment of cardiac arrhythmias. A risk-benefit appraisal.
    Capucci A; Boriani G
    Drug Saf; 1995 Jan; 12(1):55-72. PubMed ID: 7741984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tolerability and antiarrhythmic efficacy of disopyramide compared to lignocaine in selected patients with suspected acute myocardial infarction.
    Rønnevik PK; Gundersen T; Abrahamsen AM
    Eur Heart J; 1987 Jan; 8(1):19-24. PubMed ID: 2880718
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute oral antiarrhythmic testing with disopyramide.
    García-Barreto D; Toruncha A; Gonzalez-Gomez A; Llerena L; Groning E; Hernandez-Cañero A
    Clin Cardiol; 1981; 4(6):330-5. PubMed ID: 7326884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Propafenone: a new agent for ventricular arrhythmia.
    Podrid PJ; Lown B
    J Am Coll Cardiol; 1984 Jul; 4(1):117-25. PubMed ID: 6376591
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical experience with propafenone for cardiac arrhythmias in the young.
    Heusch A; Kramer HH; Krogmann ON; Rammos S; Bourgeous M
    Eur Heart J; 1994 Aug; 15(8):1050-6. PubMed ID: 7527342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Benign symptomatic premature ventricular complexes: short- and long-term efficacy of antiarrhythmic drugs and radiofrequency ablation.
    Stec S; Sikorska A; Zaborska B; Kryński T; Szymot J; Kułakowski P
    Kardiol Pol; 2012; 70(4):351-8. PubMed ID: 22528707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Treatment of ectopic ventricular activity with palpitin (disopyramide)].
    Penkov N; Mitkova M; Kaponov Kh; Karastatev D
    Vutr Boles; 1987; 26(2):54-7. PubMed ID: 2440188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.